Developing Drug Products in an Aging Society

Lieferzeit: Lieferbar innerhalb 14 Tagen

267,49 

From Concept to Prescribing, AAPS Advances in the Pharmaceutical Sciences Series 24

ISBN: 3319430971
ISBN 13: 9783319430973
Herausgeber: Sven Stegemann
Verlag: Springer Verlag GmbH
Umfang: xviii, 771 S., 11 s/w Illustr., 85 farbige Illustr., 771 p. 96 illus., 85 illus. in color.
Erscheinungsdatum: 05.12.2016
Auflage: 1/2017
Produktform: Gebunden/Hardback
Einband: Gebunden

Focuses on drug product development and prescribing for older patients from a multidisciplinary and global perspective Provides practical guidelines for developing drugs for this population Discusses regulatory pathways for medicines for older patients

Artikelnummer: 9534255 Kategorie:

Beschreibung

This book aims to address the major aspects of future drug product development and therapy for older adults, giving practical guidance for the rational product and clinical development and prescribing of drug products to this ever growing segment of the population. With authors coming from key "aging" markets such as Europe, the USA, China and Japan, the book will provide valuable information for students, scientists, regulators, practitioners, and other healthcare professionals from academia, industry and regulatory bodies.

Autorenporträt

Sven Stegemann is the endowed professor for Patient-Centric Drug Product Design and Manufacturing at the Graz University of Technology and Director of Pharmaceutical Business Development at Capsugel. He is scientist, professor and advocate for multidisciplinary research on patient-centric drug products and affordable medicines. Prof. Stegemann trains the next generation of pharmaceutical scientists. His professional experience spans all stages of drug development and manufacturing--from early development through commercial manufacturing.His passion and research led him to found the Geriatric Medicine Society e.V. in 2009, a multidisciplinary network that aims to facilitate the development of age-appropriate medicines that older patients can easily and safely take. He also serves in various organizations as chairman or committee member to progress pharmaceutical sciences.He has established a focus group on patient-centric drug development through the American Association of Pharmaceutical Scientists (AAPS).As This is integral to improving the quality of life of patients in the future.He has spoken at innumerable conferences around the world on patient-centric drug delivery, pharmaceutical product development for special patient populations, multiparticulate technologies, adherence, geriatric drug delivery, quality by design and added value generics.

Herstellerkennzeichnung:


Springer Verlag GmbH
Tiergartenstr. 17
69121 Heidelberg
DE

E-Mail: juergen.hartmann@springer.com

Das könnte Ihnen auch gefallen …